Steven M. Hannick
AbbVie (United States)(US)
Publications by Year
Research Areas
Chemical Synthesis and Analysis, Click Chemistry and Applications, Ion Channels and Receptors, Pain Mechanisms and Treatments, Synthesis and biological activity
Most-Cited Works
- → Potent, Orally Active Heterocycle-Based Combretastatin A-4 Analogues: Synthesis, Structure−Activity Relationship, Pharmacokinetics, and In Vivo Antitumor Activity Evaluation(2002)420 cited
- → An improved procedure for the Blaise reaction: a short, practical route to the key intermediates of the saxitoxin synthesis(1983)176 cited
- → Novel Transient Receptor Potential Vanilloid 1 Receptor Antagonists for the Treatment of Pain: Structure−Activity Relationships for Ureas with Quinoline, Isoquinoline, Quinazoline, Phthalazine, Quinoxaline, and Cinnoline Moieties(2005)163 cited
- → Stereocontrolled synthesis of C2-symmetric and pseudo-C2-symmetric diamino alcohols and diols for use in HIV protease inhibitors(1992)91 cited
- → Identification of (R)-1-(5-tert-Butyl-2,3-dihydro-1H-inden-1-yl)-3-(1H-indazol-4-yl)urea (ABT-102) as a Potent TRPV1 Antagonist for Pain Management(2008)80 cited
- → Reduction of an Enaminone: Synthesis of the Diamino Alcohol Core of Ritonavir(1999)54 cited
- → Efficient syntheses of protected (2s,3s)-2,3-bis(hydroxymethyl)cyclobutanone, key intermediates for the synthesis of chiral carbocyclic analogues of oxetanocin(1990)37 cited
- → Discovery of TRPV1 antagonist ABT-116(2010)21 cited
- → Discovery of Novel Aminotetralines and Aminochromanes as Selective and Competitive Glycine Transporter 1 (GlyT1) Inhibitors(2018)15 cited
- → A stereoselective and scalable synthesis of a conformationally constrained S1P1 agonist(2009)14 cited